The MR Neuroimaging Core, new to the ADRC in this competing renewal, serves two basic roles: l) MR imaging is an essential part of the clinical evaluation performed within the Clinical Core but the wealth of information available from the images has not until now been accessible to investigators for systematic review and quantitative analysis. The concept that the radiology report is an adequate summary of the image data is no longer tenable as quantitative morphometry has become technically feasible. Hence the Core provides the highest quality clinical study, systematic archiving of the image data and technological development of software tools for morphometric analyses. 2) MR techniques have evolved in terms of rapidity such that considerably more information than just high resolution anatomy can be obtained without prolongation of the MR examination time. These opportunities have been exploited by investigators elsewhere and the Core makes such tools available to investigators at this institution. These tools include IH spectroscopy with particular reference to quantitative measurement of N- acetyl metabolites such as N-acetyl aspartate, quantitative morphometry and functional MRI. The MR examination performed in vivo contains information that can be considered to be equivalent to the brain bank of the Neuropathology Core. The MR Neuroimaging Core is the repository for these image data and for the development of the tools for quantitative processing. As the MR technology evolves, the MR Neuroimaging Core implements new applications to acquire new information for ADRC investigators. As this is the mandate of the MR Research Program and involves no cost to the MR Neuroimaging Core, the ADRC capitalizes on the institutional investment in neuroimaging for ADRC investigators. Although this Core is closely connected to the Administrative, Clinical and Neuropathology Cores, the three Projects of Drs. Ferrell, Reynolds and Becker and the Pilot Project of Dr. Thulborn as well as other federally funded grants outside the ADRC, the full impact of this Core has yet to be made, given the recent formation of the MR Research Program at UPMC on which it is based.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005133-16S1
Application #
6098025
Study Section
Project Start
1999-08-01
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Kamboh, M Ilyas (2018) A Brief Synopsis on the Genetics of Alzheimer's Disease. Curr Genet Med Rep 6:133-135
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Rodakowski, Juleen; Reynolds 3rd, Charles F; Lopez, Oscar L et al. (2018) Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment. J Appl Gerontol 37:665-676
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Ritzel, Rodney M; Lai, Yun-Ju; Crapser, Joshua D et al. (2018) Aging alters the immunological response to ischemic stroke. Acta Neuropathol 136:89-110
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Cohen, Ann D; McDade, Eric; Christian, Brad et al. (2018) Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition. Alzheimers Dement 14:743-750

Showing the most recent 10 out of 667 publications